DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Larotaxel
Larotaxel
Tanibirumab (CUI C3490677) Add to Cart
Supportive Oncology
Analytics for Improved Cancer Screening and Treatment John
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
(12) United States Patent (10) Patent No.: US 8,512,679 B2 Hyde Et Al
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Download Report
411 Development of Cross-Resistance in Urothelial Cancer Cell Lines with Acquired Resistance Against Gemcitabine and Cisplatin
Microtubule-Binding Agents: a Dynamic Field of Cancer Therapeutics. Charles Dumontet, Mary Ann Jordan
WO 2010/091198 Al
Jevtana, INN-Cabazitaxel
(12) United States Patent (10) Patent No.: US 9,345,766 B2 Zhang Et Al
National Horizon Scanning Centre
New Directions for Biologic Targets in Urothelial Carcinoma
Pharmaabkommen A1 E
Novel Secondary Metabolites from Endophytic Marine-Derived Fungi
These Results Are Supplied for Informational Purposes Only
Top View
(12) United States Patent (10) Patent No.: US 9,512,107 B2 Cianchetta Et Al
1111111111111111111In11111
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
Recent Advances of Taxol-Loaded Biocompatible Nanocarriers Embedded in Natural Polymer-Based Hydrogels
(12) United States Patent (10) Patent No.: US 8,901,133 B2 Ren Et Al
Wo 2009/120697 A2
(12) United States Patent (10) Patent No.: US 8,962,275 B2 Liang Et Al
WO 2016/066594 Al 6 May 2016 (06.05.2016) P O P C T
UNIVERSITY of CALIFORNIA Los Angeles the Effect of Clinical Trial
Tepzz 5 58¥Zb T
Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity
TESIS DOCTORAL Facultad De Farmacia Departamento De
University of Medicine and Dentistry of New Jersey
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Medicines & Vaccines in Development for Cancer
These Results Are Supplied for Informational Purposes Only
These Results Are Supplied for Informational Purposes Only
WO 2015/051244 Al 9 April 2015 (09.04.2015) P O P C T
Improving the Anti-Tumour Efficacy of Albendazole
Microtubule-Binding Agents: a Dynamic Field of Cancer Therapeutics
The Use of Chemotherapy Regimens Carrying a Moderate Or High Risk Of
Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT
Predicted Tyr-Phospho-Motif